S 705 · 119th Congress
Innovation in Pediatric Drugs Act of 2025
This bill gives the FDA more power to require drug companies to test their medications on children, specifically for rare diseases. Right now, companies that make drugs for rare conditions (called orphan drugs) usually don't have to study how those drugs work in kids. This bill changes that by letting the FDA demand…
- Sponsor
- Reed, Jack (D-Rhode Island)
- Introduced
- 2025-02-25
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)
Digging through Congress... 🔍